Antipeptide antibodies reveal interrelationships of MBP 200 and MBP 235: Unique apoB-specific receptors for triglyceride-rich lipoproteins on human monocyte-macrophages

Journal of Lipid Research

Volumn 40, Issue 4, 1999, Pages 744-752

  Bradley, William A ^a   Brown, Matthew L ^a   Ramprasad, M P ^b   Li, Ran ^a   Song, Ruiling ^a   Gianturco, Sandra H ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

ApoB 48; Atherosclerosis; Chylomicrons; Foam cell; Hypertriglyceridemia

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B48; BINDING PROTEIN; LIPOPROTEIN RECEPTOR; MEMBRANE BINDING PROTEIN 200; MEMBRANE BINDING PROTEIN 235; PEPTIDE ANTIBODY; RECEPTOR PROTEIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CHO CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTER; FOAM CELL; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; LIGAND BINDING; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEQUENCE ANALYSIS; THROMBOSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; CHO CELLS; CRICETINAE; EPITOPES; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; LIPOPROTEINS; MACROPHAGES; MONOCYTES; PEPTIDES; RECEPTORS, LIPOPROTEIN; SEQUENCE ANALYSIS; TRIGLYCERIDES;

EID: 0032914598     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71: 343-353.
2. Zhang, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
3. Nakashima, Y., A. S. Plump, E. W. Raines, J. L. Breslow, and R. Ross. 1994. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14: 133-140.
4. Reddick, R. L., S. H. Zhang, and N. Maeda. 1994. Atherosclerosis in mice lacking apoE evaluation of lesional development and progression. Arterioscler. Thromb. 14: 141-147.
5. Bellosta, S., R. W. Mahley, D. A. Sanan, J. Murata, D. L. Newland, J. M. Taylor, and R. E. Pitas. 1995. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96: 2170-2179.
6. Gianturco, S. H., W. A. Bradley, A. M. Gotto, Jr., J. D. Morrisett, and D. L. Peavy. 1982. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J. Clin. Invest. 70: 168-178.
7. 1 macrophages. J. Lipid Res. 27:412-420.
8. Gianturco, S. H., A. H-Y. Lin, S. C. Hwang, J. Young, S. A. Brown, D. P. Via, and W. A. Bradley. 1988. Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins. J. Clin. Invest. 82: 1633-1643.
9. Gianturco, S. H., M. P. Ramprasad, A. Lin, R. Song, and W. A. Bradley. 1994. Cellular binding site and membrane binding proteins for triglyceride-rich lipoproteins in human monocyte-macrophages and THP-1 monocytic cells. J. Lipid Res. 35: 1674-1687.
10. Ramprasad, M. P., R. Li, W. A. Bradley, and S. H. Gianturco. 1995. Human THP-1 monocyte-macrophage membrane binding proteins: distinct receptor(s) for triglyceride-rich lipoproteins. Biochemistry. 34: 9126-9135.
11. Ramprasad, M. P., R. Li, S. H. Gianturco, and W. A. Bradley. 1995. Purification of the human THP-1 monocyte-macrophage triglyceride-rich lipoprotein receptor. Biochem. Biophys. Res. Commun. 210: 491-497.
12. Gianturco, S. H., M. P. Ramprasad, R. Song, R. Li, M. L. Brown, and W. A. Bradley. 1998. Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor. Arterioscler. Thromb. Vasc. Biol. 18: 968-976.
13. Gianturco, S. H., and W. A. Bradley. 1986. The role of apolipoprotein processing in receptor recognition. Methods Enzymol. 129: 319-344.
14. Lindgren, F. T., L. C. Jensen, and F. T. Hatch. 1972. The isolation and quantitative analysis of serum lipoproteins in blood lipids and lipoproleins. In Blood Lipids and Lipoproteins. G. J. Nelson, editor. Wiley Interscience, New York. 181-274.
15. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
16. Helenius, A., and K. Simons. 1971. Removal of lipids from human plasma low density lipoprotein by detergents. Biochemistry. 10: 2542-2547.
17. Gianturco, S. H., A. M. Gotto, Jr., R. L. Jackson, J. R. Patsch, H. D. Sybers, O. D. Taunton, D. L. Yeshurun, and L. C. Smith. 1978. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia. J. Clin. Invest. 61: 320-328.
18. Cooper, A. D. 1997. Hepatic uptake of chylomicron remnants. J. Lipid Res. 38:2173-2192.
19. Choi, S. Y., P. Sivaram, D. E. Walker, L. K. Curtiss, D. G. Gretch, S. L. Sturley, A. D. Attie, R. J. Deckelbaum, and I. J. Goldberg. 1995. Lipoprotein lipase association with lipoproteins involves protein-protein interaction with apolipoprotein B. J. Biol. Chem. 270: 8081-8086.
20. Fredrickson, D. S., J. L. Goldstein, and M. S. Brown. 1978. The familial hyperlipoproteinemias. In The Metabolic Basis of Inherited Diseases. J. G. Stanbury, M. F. Wyngaarden, and D. S. Fredrickson, editors. McGraw-Hill, New York. 604-655.
21. Parker, F., J. D. Bagdade, G. F. Odland, and E. L. Bierman. 1970. Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: a correlative lipid biochemical, histochemical, and electron microscopic study. J. Clin. Invest. 49: 2172-2187.
22. Li, X., J. C. Koons, R. L. Benza, M. Parks, V. K. Varma, W. A. Bradley, S. H. Gianturco, K. B. Taylor, J. R. Grammar, E. M. Tabengwa, and F. M. Booyse. 1996. Hypertriglyceridemic VLDL decreases plasminogen binding to endothelial cells and surface localized fibrinolysis. Biochemistry. 35: 6080-6088.
23. Li, X., H. E. Grenett, R. L. Benza, S. Demissie, S. L. Brown, E. M. Tabengwa, S. H. Gianturco, W. A. Bradley, G. M. Fless, F. M. Booyse. 1997. Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17: 3215-3223.